MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-20-0010711
Garle Impex Private Limited - pharma in Gwalior, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.67 Cr
▲ 15% YoY
Net profit · FY 2025
₹7.07 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹35.05 Lakh
EBITDA margin 5.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2.7 Cr
Satisfied ₹50 Lakh
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
About Garle Impex Private Limited
Data last updated:
Garle Impex Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 June 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U52206MP2004PTC016691. Its GSTIN is 23AACCG2814R1ZH (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Kumar Goyal and Rukhmani Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Narayandas Market Chins Ki Goth Lashkar, Gwalior, Madhya Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.67 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹7.07 Lakh (net margin 1.1%) and EBITDA of ₹35.05 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹2.7 Cr and satisfied charges of ₹50 Lakh on record. Court records list 10 cases involving the company, including 10 filed against it; 2 cases are pending.
Garle Impex Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-20-0010711). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website garlegroup.org.
Company details
CIN U52206MP2004PTC016691
Registration Number 016691
Incorporation Date 11 June 2004
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-20-0010711
Key People
Raj Kumar Goyal Director Rukhmani Goyal Director Recognitions & Rankings of Garle Impex
Contact details
Garle Impex Private Limited's registered office is in Gwalior, Madhya Pradesh. Its website is garlegroup.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNarayandas Market Chins Ki Goth Lashkar, Gwalior, Madhya Pradesh, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Garle Impex Private Limited, buy the company report.
Comprehensive company report
Garle Impex Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Garle Impex is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Garle Impex Private Limited, buy the company report.
Financials of Garle Impex Private Limited
FY 2025 filings availableGarle Impex Private Limited reported revenue of ₹6.67 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹6.67 Cr ▲ 15%
Net profit · FY 2025
₹7.07 Lakh margin 1.1%
EBITDA · FY 2025
₹35.05 Lakh margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 7%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 53%
5 years · compounded
▼ 41%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 15% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹6.67 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Garle Impex Private Limited, buy the company report.
Board of directors of Garle Impex Private Limited
Garle Impex has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kumar Goyal Also directs: Ganc Bio Healthcare Private Limited | Director | 11 Jun 2004 | 22 Years 4 Months | Current |
| Rukhmani Goyal | Director | 11 Jun 2004 | 22 Years 4 Months | Current |
Peer comparison
Garle Impex Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anishya Lifecare Private Limited | ₹6.7 Cr (FY 2024) | 799.0% | Ahmedabad, Gujarat, India | |||
| TPPL Pharmaceuticals Private Limited | ₹6.69 Cr (FY 2025) | -3.0% | Jaipur, Rajasthan, India | |||
| Garle Impex Private Limitedthis company | ₹6.67 Cr (FY 2025) | ₹7.07 Lakh | 1.1% | 15.0% | Gwalior, Madhya Pradesh, India | |
| Raghava Diagnostic Services Private Limited | ₹6.64 Cr (FY 2025) | -74.0% | Bengaluru, Karnataka, India | |||
| Ostrich Pharmaceuticals Private Limited | ₹6.63 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India |
To see the full peer comparison of Garle Impex Private Limited, buy the company report.
Auditor
Garle Impex Private Limited is audited by ATUL KUMAR & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL KUMAR & ASSOCIATES | FY 2024 | 001982C |
Shareholding
The shareholding of Garle Impex Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Garle Impex Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.7 Cr
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Sep 2025 | 101186487 | Others | ₹1.5 Cr | Open | |
| 23 Jan 2024 | 100885317 | Axis Bank Limited | ₹1.2 Cr | Open | |
| 23 May 2015 | 10575635 | Icici Bank Limited | ₹50 Lakh | Satisfied |
To see the full charge records of Garle Impex Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Garle Impex Private Limited has 10 court cases on record: 10 filed against it. 2 cases are pending and 8 are disposed.
Total cases
10
Filed against the company
10
Pending
2
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 2 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Civil suit | Filed against the company by Star Biomed Pvt. Ltd. | Pending |
| District court, Faridabad, Haryana | Execution petition | Filed against the company by M/S Polymedicure Ltd. | Disposed |
| District court, North, Delhi | Cheque dishonour complaint | Filed against the company by M/S Bioline Diagnostics LLP | Disposed |
| District court, South East, Delhi | Civil suit | Filed against the company by J. Mitra and Co. Pvt. Ltd. | Disposed |
| District court, Faridabad, Haryana | Execution petition | Filed against the company by Poly Medicure Limited | Disposed |
To see the full case history of Garle Impex Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Garle Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Garle Impex has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCG2814R1ZH | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Garle Impex Private Limited, buy the company report.
Recent activity
Garle Impex Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Raj Kumar Goyal was appointed as Director on 11 Jun 2004.
AGM
Garle Impex Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 150.00 Lakh with Charge ID 101186487 was registered on 20 Sep 2025.
Filing
Garle Impex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge registered on 23 May 2015 via Charge ID 10575635 with Icici Bank Limited was fully satisfied on 27 Feb 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 120.00 Lakh with Charge ID 100885317 was registered on 23 Jan 2024.
Charges
A charge with Icici Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 10575635 was registered on 23 May 2015.
Appointed
Raj Kumar Goyal was appointed as Director.
Appointed
Rukhmani Goyal was appointed as Director.
Incorporation
11 Jun 2004
Garle Impex Private Limited was registered on 11 Jun 2004 with Roc Gwalior & aged 22 years 4 months as per MCA records.
Frequently asked questions
Garle Impex is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 June 2004 (22+ years old) and is registered under CIN U52206MP2004PTC016691.
Garle Impex has 2 current directors:
- Raj Kumar Goyal - Director
- Rukhmani Goyal - Director
The latest financial statements of Garle Impex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Garle Impex is 23AACCG2814R1ZH, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Garle Impex is U52206MP2004PTC016691. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Garle Impex has 10 court cases on record: 10 filed against it. 2 are pending.
Garle Impex was incorporated on 11 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Garle Impex by revenue are Anishya Lifecare Private Limited, TPPL Pharmaceuticals Private Limited, Raghava Diagnostic Services Private Limited, Ostrich Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Raj Kumar Goyal was appointed as Director on 11 Jun 2004. Rukhmani Goyal was appointed as Director on 11 Jun 2004.
Yes, Garle Impex is registered as a small enterprise under Udyam registration (number: UDYAM-MP-20-0010711).
Garle Impex can be reached through the website garlegroup.org. Its registered office is in Gwalior, Madhya Pradesh, India.